Form 4 for OFIX Orthofix Medical Inc.
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001209191-23-023453 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-05 | 2023-04-03 | OFIX | Kenny Kevin J. | Pres of Gbl Spine | F - Tax | $16.75 | -1,956 | 141.3K | -1% | -$32.8K |
| D | 2023-04-05 | 2023-04-04 | OFIX | Kenny Kevin J. | Pres of Gbl Spine | A - Grant | $0.00 | +7,449 | 148.7K | +5% | $0 |
| DM | 2023-04-05 | 2023-04-04 | OFIX | Kenny Kevin J. | Pres of Gbl Spine | A - Grant | $0.00 | +23.0K | 5,959 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | F | D | 1,956 | $16.75 | 141,275 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-04 | A | A | 7,449 | $0.00 | 148,724 | D | — | — | (F1) Includes 121,401 previously reported unvested restricted stock units. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-04-04 | A | A | 17,061 | $0.00 | 17,061 | D | $16.78 · — to 2033-04-04 | 17,061 Common Stock | (F3) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. |
| 4 | Derivative | Performance Share Units | 2023-04-04 | A | A | 5,959 | $0.00 | 5,959 | D | $0.00 · — to — | 5,959 Common Stock | (F2) Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The Synergy Target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy Target is achieved), or 0% (if less than 80% of the Synergy Target is achieved). |